Two new studies suggest that the diabetes medication Ozempic may double the risk of a rare but serious condition that damages ...

What happened with Novo Nordisk stock? On Dec. 20, Novo announced results from a phase 3 clinical trial surrounding one of ...

Pensioenfonds Huisartsen, the occupational pension fund for general practitioners in the Netherlands, has published the names ...

The proposed Biosecure Act as well as the diversification of American and European firms away from China are expected to help ...

Kennedy Jr., President-elect Donald Trump’s nominee to head the US Department of Health and Human Services, who has expressed reservations about the pharma industry — and its new wonder drug category.

Known as Evoke, the study has been testing an oral version of semaglutide, the active ingredient in Novo’s Ozempic and Wegovy ...